BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10912478)

  • 1. Trends over time in Helicobacter pylori gastritis in Kenya.
    McFarlane GA; Wyatt J; Forman D; Lachlan GW
    Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):617-21. PubMed ID: 10912478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and Regulation of the Innate Immune Response in Helicobacter pylori Infection.
    Gobert AP; Wilson KT
    Cell Mol Gastroenterol Hepatol; 2022; 13(5):1347-1363. PubMed ID: 35124288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients.
    Naylor GM; Gotoda T; Dixon M; Shimoda T; Gatta L; Owen R; Tompkins D; Axon A
    Gut; 2006 Nov; 55(11):1545-52. PubMed ID: 16603635
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lim NR; Chung WC
    Korean J Gastroenterol; 2023 Oct; 82(4):171-179. PubMed ID: 37876256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter Pylori and Gastric Cancer: An Update in the Literature.
    Toro DH; Bofill-Garcia A; Anzalota-Del Toro M
    P R Health Sci J; 2024 Mar; 43(1):9-17. PubMed ID: 38512756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Helicobacter Pylori Infection in the Development of Gastric Cancer - Review of the Literature.
    Chivu RF; Bobirca F; Melesteu I; Patrascu T
    Chirurgia (Bucur); 2024 Apr; 119(eCollection):1-10. PubMed ID: 38657111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk.
    Masuyama H; Yoshitake N; Sasai T; Nakamura T; Masuyama A; Zuiki T; Kurashina K; Mieda M; Sunada K; Yamamoto H; Togashi K; Terano A; Hiraishi H
    Digestion; 2015; 91(1):30-6. PubMed ID: 25632914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases.
    Dore MP; Erre GL; Piroddu J; Pes GM
    Helicobacter; 2023 Dec; 28(6):e13025. PubMed ID: 37792567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of gastric carcinoma in patients with atrophic gastritis and intestinal metaplasia.
    Kang JY; Finlayson C; Maxwell JD; Neild P
    Gut; 2002 Dec; 51(6):899. PubMed ID: 12427804
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and safety of Moluodan in the treatment of precancerous lesions of gastric cancer: A randomized clinical trial.
    Zou TH; Gao QY; Liu S; Li YQ; Meng XJ; Zhang GX; Tian ZB; Zou XP; He S; Hou XH; Lin R; Li JN; Zhou ZY; Li Y; Wang MC; Wang BM; Tian A; Chen SJ; Cao Q; Li LP; Wang ZR; Shen XZ; Liu BR; Yan XY; Chen YX; Fang JY
    J Dig Dis; 2024 Jan; 25(1):27-35. PubMed ID: 38342693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The occurrence, progression and development of four types of gastric mucosal atrophic lesions and their histopathological characteristics.
    Wang Y; Zhou J; Meng N; Yang B; Zhu C; Jiang B; Wang S; Chen X
    Gastric Cancer; 2023 Sep; 26(5):721-733. PubMed ID: 37328675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History and clinical guidelines for chronic atrophic gastritis and the assessment of gastric cancer risk.
    Delgado-Guillena P; Velamazan-Sandalinas R; Jiménez Sánchez J; Fuentes-Valenzuela E; García-Morales N; Cuatrecasas M; Jimeno M; Moreira L; Albéniz E
    Gastroenterol Hepatol; 2023 Nov; 46(9):727-731. PubMed ID: 37708969
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastric cancer risk in autoimmune gastritis: evidence versus opinion.
    Rugge M; Genta RM; Malfertheiner P; Graham DY
    Gut; 2024 Feb; 73(3):555-556. PubMed ID: 36849227
    [No Abstract]   [Full Text] [Related]  

  • 14. Conclusion that autoimmune gastritis does not predispose to gastric cancer is unproven.
    Waldum HL
    Gut; 2024 Jan; 73(2):379. PubMed ID: 36693711
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between salt intake and gastric atrophy by Helicobacter pylori infection: first results from the Epidemiological Investigation of Gastric Malignancy (ENIGMA).
    Knaze V; Freisling H; Cook P; Heise K; Acevedo J; Cikutovic M; Wagner KH; Marculescu R; Ferreccio C; Herrero R; Park JY
    Eur J Nutr; 2023 Aug; 62(5):2129-2138. PubMed ID: 36964250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer.
    Repetto O; De Re V; Giuffrida P; Lenti MV; Magris R; Venerito M; Steffan A; Di Sabatino A; Cannizzaro R
    Gastric Cancer; 2021 May; 24(3):666-679. PubMed ID: 33620602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not all that is corpus restricted is necessarily autoimmune.
    Lahner E; Dilaghi E; Dottori L; Annibale B
    Gut; 2023 Nov; 72(12):2384-2385. PubMed ID: 36357166
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of infections in the causation of cancer in Kenya.
    Tuei VC; Maiyoh GK; Ndombera FT
    Cancer Causes Control; 2022 Dec; 33(12):1391-1400. PubMed ID: 36087193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Helicobacter pylori infection, chronic gastritis, and intestinal metaplasia in Mozambican dyspeptic patients.
    Carrilho C; Modcoicar P; Cunha L; Ismail M; Guisseve A; Lorenzoni C; Fernandes F; Peleteiro B; Almeida R; Figueiredo C; David L; Lunet N
    Virchows Arch; 2009 Feb; 454(2):153-60. PubMed ID: 19101725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological profile of gastritis in adult patients seen at a referral hospital in Kenya.
    Kalebi A; Rana F; Mwanda W; Lule G; Hale M
    World J Gastroenterol; 2007 Aug; 13(30):4117-21. PubMed ID: 17696233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.